Results 281 to 290 of about 793,336 (333)

Comparing drug combinations for graft-versus-host disease prophylaxis using the U.S. Food and Drug Administration Adverse Event Reporting System. [PDF]

Clin Transplant Res
Ogura T, Shiraishi C, Urawa A.
europepmc   +1 more source

Drug combinations targeting FAK and MEK overcomes tumour heterogeneity in glioblastoma

Furqan M, Elliott RJR, Nagle P, Dawson JC, Masalmeh R, Garcia VA, Munro AF, Drake C, Morrison GM, Pollard SM, Ebner D, Brunton VG, Frame MC, Carragher NO.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Combination Drug Therapy

Journal of the American Medical Directors Association, 2005
Caring for the elderly nursing home patient has never been more clinically complex or administratively more troublesome. Patients carry with them a greater burden of disease with increasing frailty and vulnerability. More drugs are being used for more problems.
Eric G, Tangalos, Barbara J, Zarowitz
openaire   +2 more sources

Drug–drug combinations revisited

European Journal of Hospital Pharmacy, 2013
The use of fixed-dose combinations (FDCs) in the daily practice of pharmacotherapy is increasing after years in the shadows. The main reasons for this renewed popularity are the increasing number of drugs prescribed per patient and the complexity of current pharmacotherapy.
Bjerrum, Ole Jannik, Gautam, Yvonne, Honoré, Per Gustaf Hartvig, Vana, Vasiliki   +3 more
openaire   +2 more sources

Combination drugs...

Nursing, 2006
  +14 more sources

Combinations of drugs

Multiple Sclerosis Journal, 1996
As a result of recent therapeutic trials, recombinant Interferon beta (r/FNβ)-1b and-1a as well as Copolymer 1 (COP 1) and to some extent unspecific immunosuppressants have been accepted as partially efficient treatments of relapsing-remitting MS. In view of partially effective single treatments, the question arises if combination of two or even more ...
openaire   +2 more sources